Answers to complex questions cannot be derived from "simple" trials

This publication has 15 references indexed in Scilit:

• Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.
  Circulation, 1991
• SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group.
  BMJ, 1991
• Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials.
  Circulation, 1990
• Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
  Journal of the American College of Cardiology, 1990
• GISSI-2: mortality plus extensive left-ventricular damage as "end-point"
  The Lancet, 1990
• Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1989
• Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.
  Circulation, 1988
• DIFFERENCE BETWEEN HERPES SIMPLEX VIRUS TYPE I AND TYPE 2 NEONATAL ENCEPHALITIS IN NEUROLOGICAL OUTCOME
  Published by Elsevier ,1988
• THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY
  The Lancet, 1988
• A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1987